These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 20537761)

  • 21. Beyond peroxisome proliferator-activated receptor gamma signaling: the multi-facets of the antitumor effect of thiazolidinediones.
    Weng JR; Chen CY; Pinzone JJ; Ringel MD; Chen CS
    Endocr Relat Cancer; 2006 Jun; 13(2):401-13. PubMed ID: 16728570
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular mechanisms underlying the pro-inflammatory synergistic effect of tumor necrosis factor alpha and interferon gamma in human microvascular endothelium.
    Lombardi A; Cantini G; Mello T; Francalanci M; Gelmini S; Cosmi L; Santarlasci V; Degl'Innocenti S; Luciani P; Deledda C; Annunziato F; Forti G; Galli A; Serio M; Luconi M
    Eur J Cell Biol; 2009 Dec; 88(12):731-42. PubMed ID: 19782427
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dysregulation of secretion of CXC alpha-chemokine CXCL10 in papillary thyroid cancer: modulation by peroxisome proliferator-activated receptor-gamma agonists.
    Antonelli A; Ferrari SM; Fallahi P; Frascerra S; Piaggi S; Gelmini S; Lupi C; Minuto M; Berti P; Benvenga S; Basolo F; Orlando C; Miccoli P
    Endocr Relat Cancer; 2009 Dec; 16(4):1299-311. PubMed ID: 19755523
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hypoglycemic action of thiazolidinediones/peroxisome proliferator-activated receptor gamma by inhibition of the c-Jun NH2-terminal kinase pathway.
    Díaz-Delfín J; Morales M; Caelles C
    Diabetes; 2007 Jul; 56(7):1865-71. PubMed ID: 17416798
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Activation of peroxisome proliferator-activated receptor gamma suppresses telomerase activity in vascular smooth muscle cells.
    Ogawa D; Nomiyama T; Nakamachi T; Heywood EB; Stone JF; Berger JP; Law RE; Bruemmer D
    Circ Res; 2006 Apr; 98(7):e50-9. PubMed ID: 16556873
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Thiazolidinediones inhibit TNFalpha induction of PAI-1 independent of PPARgamma activation.
    Liu HB; Hu YS; Medcalf RL; Simpson RW; Dear AE
    Biochem Biophys Res Commun; 2005 Aug; 334(1):30-7. PubMed ID: 15990085
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Peroxisome proliferator-activated receptor gamma regulates expression of signal transducer and activator of transcription 5A.
    Olsen H; Haldosén LA
    Exp Cell Res; 2006 May; 312(8):1371-80. PubMed ID: 16457814
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prostaglandin-J(2) upregulates expression of matrix metalloproteinase-1 independently of activation of peroxisome proliferator-activated receptor-gamma.
    Józkowicz A; Huk I; Nigisch A; Cisowski J; Weigel G; Dulak J
    Acta Biochim Pol; 2003; 50(3):677-89. PubMed ID: 14515149
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The glucagon-like peptide 1 receptor agonist enhances intrinsic peroxisome proliferator-activated receptor γ activity in endothelial cells.
    Onuma H; Inukai K; Kitahara A; Moriya R; Nishida S; Tanaka T; Katsuta H; Takahashi K; Sumitani Y; Hosaka T; Ishida H
    Biochem Biophys Res Commun; 2014 Aug; 451(2):339-44. PubMed ID: 25109805
    [TBL] [Abstract][Full Text] [Related]  

  • 30. PPARγ signaling and emerging opportunities for improved therapeutics.
    Wang S; Dougherty EJ; Danner RL
    Pharmacol Res; 2016 Sep; 111():76-85. PubMed ID: 27268145
    [TBL] [Abstract][Full Text] [Related]  

  • 31. β (CCL2) and α (CXCL10) chemokine modulations by cytokines and peroxisome proliferator-activated receptor-α agonists in Graves' ophthalmopathy.
    Antonelli A; Ferrari SM; Frascerra S; Ruffilli I; Pupilli C; Bernini G; Sellari-Franceschini S; Gelmini S; Ferrannini E; Fallahi P
    J Endocrinol; 2012 May; 213(2):183-91. PubMed ID: 22378921
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cardioprotection from oxidative stress in the newborn heart by activation of PPARγ is mediated by catalase.
    Chen T; Jin X; Crawford BH; Cheng H; Saafir TB; Wagner MB; Yuan Z; Ding G
    Free Radic Biol Med; 2012 Jul; 53(2):208-15. PubMed ID: 22609424
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Peroxisome Proliferator-Activated Receptor γ Regulates the V-Ets Avian Erythroblastosis Virus E26 Oncogene Homolog 1/microRNA-27a Axis to Reduce Endothelin-1 and Endothelial Dysfunction in the Sickle Cell Mouse Lung.
    Kang BY; Park K; Kleinhenz JM; Murphy TC; Sutliff RL; Archer D; Hart CM
    Am J Respir Cell Mol Biol; 2017 Jan; 56(1):131-144. PubMed ID: 27612006
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antiangiogenic effect of rosiglitazone is mediated via peroxisome proliferator-activated receptor gamma-activated maxi-K channel opening in human umbilical vein endothelial cells.
    Kim KY; Cheon HG
    J Biol Chem; 2006 May; 281(19):13503-13512. PubMed ID: 16527820
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evidence that peroxisome proliferator-activated receptor γ suppresses squamous carcinogenesis through anti-inflammatory signaling and regulation of the immune response.
    Ren L; Konger RL
    Mol Carcinog; 2019 Sep; 58(9):1589-1601. PubMed ID: 31111568
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [PPARgamma as a new therapeutic target in inflammatory diseases].
    Naito Y; Yoshikawa T
    Nihon Rinsho; 2010 Feb; 68(2):341-9. PubMed ID: 20158107
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [PPARgamma agonists for the diseases of gastrointestinal tract and liver].
    Shimada T; Hiraishi H
    Nihon Rinsho; 2010 Feb; 68(2):312-6. PubMed ID: 20158102
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Senescence Alters PPARγ (Peroxisome Proliferator-Activated Receptor Gamma)-Dependent Fatty Acid Handling in Human Adipose Tissue Microvascular Endothelial Cells and Favors Inflammation.
    Briot A; Decaunes P; Volat F; Belles C; Coupaye M; Ledoux S; Bouloumié A
    Arterioscler Thromb Vasc Biol; 2018 May; 38(5):1134-1146. PubMed ID: 29545239
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pleiotropic effects of thiazolidinediones: taking a look beyond antidiabetic activity.
    Giannini S; Serio M; Galli A
    J Endocrinol Invest; 2004 Nov; 27(10):982-91. PubMed ID: 15762051
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MAPK kinases as nucleo-cytoplasmic shuttles for PPARgamma.
    Burgermeister E; Seger R
    Cell Cycle; 2007 Jul; 6(13):1539-48. PubMed ID: 17611413
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.